Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022
Monthly information regarding the total number of voting rights and
total number of shares of the Company as of November 30, 2022
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date
Total number of sharesTotal number of voting rights11/30/2022
94,137,145
Total gross of voting rights: 94,137,145
Total net* of voting rights: 93,966,891
* Total net = total number of voting rights attached to shares – shares without voting rights


The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.